More on MYGN
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $15.99 |
|
|||
| Open | $15.99 | ||||
| 52 Wk High | $45.34 | ||||
| 52 Wk Low | $15.92 | ||||
| Day High | $16.54 | ||||
| Day Low | $15.98 | ||||
| P/E | 6.99 | ||||
| EPS | $2.33 | ||||
| Volume | 76,403 | ||||
- Form 4 MYRIAD GENETICS INC For: Sep 21 Filed by: Munk Natalie
- Form 4 MYRIAD GENETICS INC For: Sep 21 Filed by: Ancona Margaret
- Form 4 MYRIAD GENETICS INC For: Sep 21 Filed by: Verratti Mark
- Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials
- Myriad Genetics Issues 2022 Environmental, Social and Governance Report
- Myriad Genetics and Leading Cancer Center Collaborate to Study the Use of Minimal Residual Disease Testing in Breast Cancer
- Myriad Genetics (MYGN) option implied volatility into hosting investor day
- Myriad Genetics Named to 2023 Best Workplaces in Health Care List by Fortune and Great Place To Work
- New Myriad Genetics Survey Reveals Widespread Confusion and Misconceptions About Ovarian Cancer Screening Among a Majority of Women
- Myriad Genetics to Participate in Morgan Stanley Global Healthcare Conference
Entities mentioned with MYGN
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- FDA | View Related Stories »
- 13G | View Related Stories »
- JPMorgan | View Related Stories »
- Morgan Stanley | View Related Stories »
- Piper Jaffray | View Related Stories »
- Show More...
